This week, BioIntelliSense Founder & CEO James Mault, MD, FACS, joined industry leaders including Lisa Gulker (Oracle), Esteban Rubens (Oracle) and Mitesh Patel (Ascension) at the Oracle Health Summit for a panel discussion on the “Future of Wearables.” This global forum brings together innovators and experts shaping healthcare’s next frontier and developing new solutions for some of the industry’s biggest challenges. Dr. Mault spoke about the transformative impact of medical-grade wearables like the BioButton® for shifting from traditional, episodic care to continuous, intelligent monitoring at scale and enabling early detection of patient deterioration, proactive clinical interventions, and optimized workforce efficiency. #OracleHealthSummit #FutureOfWearables #DigitalHealth #ContinuousCare #HealthcareInnovation
BioIntelliSense, Inc
Medical Device
Denver, Colorado 8,222 followers
A New Era of Continuous Health Monitoring and Clinical Intelligence
About us
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical-grade remote care from in-hospital to home. Learn how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services or visit our website at BioIntelliSense.com.
- Website
-
http://biointellisense.com
External link for BioIntelliSense, Inc
- Industry
- Medical Device
- Company size
- 51-200 employees
- Headquarters
- Denver, Colorado
- Type
- Privately Held
Locations
-
Primary
Get directions
Denver, Colorado , US
Employees at BioIntelliSense, Inc
Updates
-
In an era when health systems are facing intense budgetary and staffing pressures, hospitals need reliable, cost-effective solutions that can be integrated seamlessly to enhance clinical workflows while improving patient outcomes. The new FDA-cleared BioButton® Multi-Patient Wearable and BioDashboard System™ addresses these challenges head-on, delivering medical-grade continuous monitoring across medical surgical units, specialty care areas, emergency departments and in delivering hospital level care at home. Learn more: BioIntelliSense.com #ContinuousMonitoring #HealthCareInnovation
-
-
Dr. Geeta Nayyar, MD, MBA’s reflection on meeting BioIntelliSense founder and CEO James Mault, MD, FACS during her residency underscores how pivotal moments shape careers. It’s a privilege to see Dr. Mault's dedication inspire others as we work to advance healthcare innovation together. Thank you for sharing this inspiring memory, Dr. Nayyar!
Humanizing innovation for better health and business outcomes | Chief medical officer | Technologist | WSJ bestselling author, “Dead Wrong” | RadiantGraph | Salesforce, AT&T alum | #AI #Speaker
When I was a 20-some-year-old resident at George Washington University, I headed to grand rounds one day totally unaware that Jim Mault was going to change my life forever. In theory, physicians pause their otherwise nonstop days during grand rounds to listen to a lecture. In reality, grand rounds can also be an exercise in quiet and kind multitasking — listening deeply while also devouring lunch, whispering necessities with other residents, and keeping a watchful eye on your pager. When Jim came on stage, I froze. I put down my half-sandwich, stopped answering pages, and tuned into him like his words were gospel. “Did they just say he’s a CT surgeon?” I thought to myself. “And he works for Microsoft?” It was the first time I’d heard of a doctor working in tech, never mind a highly specialized surgeon. It seemed ludicrous at the time — no one I knew was doing that. And yet, I’d had dreams of doing *exactly* that. But the medical establishment made me feel crazy for wanting it. How could I “throw away” a solid medical background to work in tech? To what end? For what purpose? Jim answered all of those questions. He was changing the face of healthcare like no one else had before. He understood patients, the system, the clinical teams. He didn’t just want better, he demanded better. That day, I walked out of grand rounds and decided: “If that doc can do it, so can I!” Now Jim and I both sit on the board of the American Telemedicine Association, which feels surreal. I told him recently about the impact he had on me that day. He said he was touched. And then shared that now I inspire him in his work! Full circle. We all have something to offer our industries and our communities. We may not think anyone notices, but they do. You never know who you may inspire to move us all forward. Thank you for inspiring me and so many others, Jim!
-
-
We are thrilled that Fierce Healthcare has selected the medical-grade BioButton® wearable device as a finalist in the 2024 #FierceInnovationAwards! Hospital systems nationwide are deploying the multiparameter BioButton device to shift from traditional labor-intensive patient monitoring to a continuous, personalized and scalable model of care. The BioButton is transforming how patients are monitored from in-hospital to at home. This honor is a testament to the hard work, ingenuity and dedication of the team at BioIntelliSense, our amazing health system partners, and the incredible nurses and clinicians on the front lines of patient care.
-
-
Today, we’re thrilled to announce FDA clearance for the new BioIntelliSense BioButton® Multi-Patient wearable and BioDashboard™ clinical intelligence system. These additions to our growing portfolio of medical-grade, continuous patient monitoring solutions will equip hospitals with industry-leading tools for scalable exception management and automated vital sign collection. Here’s how: ➡ Rechargeable & Reusable: The BioButton Multi-Patient wearable is rechargeable and reusable, including a multi-device charging station, to provide a more cost-effective, sustainable solution for continuous patient monitoring across general care units in the hospital, as well as for hospital-at-home care. ➡ Data-Driven Exception Management: The BioDashboard's personalized, automated trending notifications enable clinicians to monitor hundreds of patients simultaneously, shifting from episodic to continuous vital sign monitoring. ➡ Enhanced Patient Care: Continuous vital sign tracking enables early detection of meaningful physiological changes, allowing for timely clinical interventions and improved patient outcomes. ➡ Workforce Efficiency: By automating vital sign capture and reducing manual tasks, the BioButton system enhances staff efficiency, reducing alert fatigue and improving response times with actionable clinical insights. ➡ Interoperable & Secure: The system integrates seamlessly with third-party platforms and EMR systems, adhering to strict privacy and security standards to support scalable virtual care programs. Learn more in Yahoo Finance: https://lnkd.in/g-fJQNnt #ContinuousCare #PatientMonitoring #BioButton
-
-
“We’re going to look back on this decade as one of the most profound moments in human healthcare on par with the discovery of immunization and antibiotics–even the x-ray machine.” – BioIntelliSense Founder and CEO James Mault, MD, FACS Dr. Mault shared his insights into the impact of modern, medical-grade wearables to accelerate the future of healthcare with M42 Health’s Managing Director and Group Chief Executive Officer Hasan Jasem Al Nowais and Microsoft’s Global Chief Medical Officer & VP of Healthcare David Rhew, M.D., M.D in Abu Dhabi. Thank you to Amandeep Bhangu for convening the panel of health leaders ushering in a new era of care. The future of healthcare is here, and it fits in the palm of your hand.
-
On September 19, BioIntelliSense CCO Carolyn Walsh heads to EY’s Digital Health on the Hill to share how continuous patient monitoring is shaping the future of healthcare. It’s a future where wireless, multiparameter wearables like the medical-grade BioButton® device keep patients connected to care beyond the hospital walls into the comfort of home. BioIntelliSense will showcase this new standard of continuous care to industry leaders and lawmakers from around the country during the panel session ‘Screening for Success: ROI of Digital Health Interventions.’ Sushma Akunuru, SVP and Chief Information Officer at Independence Blue Cross, Robert E. Connely III, Global Industry Market Leader for Healthcare at Pega, and Randy Gaboriault MS, MBA, Chief Digital and Innovation Officer at ChristianaCare will also share their insights on digital health adoption during the session, which will be moderated by Jason Rife, Health Transformation at EY. #DigitalHealthontheHill #continuouscare #futureofhealthcare
-
-
BioIntelliSense is advancing our understanding of human health here on Earth–and now in space as part of the Polaris Program's Polaris Dawn mission. The medical-grade BioButton® wearable device is currently being worn by the crew of Polaris Dawn during their historic 5-day mission. Researchers will use the physiologic data gathered before, during and after the mission to expand knowledge of what happens to the human body while in space. BioIntelliSense is proud to collaborate with the Translational Research Institute for Space Health (TRISH) to advance human health research on this groundbreaking mission. #futureofhealth #spacehealth
Liftoff!! 🚀 The Polaris Program’s Polaris Dawn has successfully launched! Congratulations to everyone involved in today's achievement, we are grateful for the opportunity to collaborate on such exciting research! The space health data collected from the Polaris Dawn crew will be stored in EXPAND and will contribute to our understanding of how spaceflight impacts human health. We’ll be closely monitoring the mission over the coming days and eagerly anticipate the crew's safe return! #SpaceHealth #TRISH (Photo: SpaceX)
-
-
Today, we’re excited to announce an exclusive license agreement with iRhythm Technologies, Inc. to use BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies within the ambulatory cardiac monitoring (ACM) market. Read more here: https://lnkd.in/g-wDcipg
-
-
At Houston Methodist, tech-enabled innovations are transforming patient care, improving efficiency and enhancing outcomes. Their approach to leveraging cutting-edge technologies, including the medical-grade BioButton™ wearable device, is a testament to the power of continuous monitoring and data-driven insights in improving healthcare delivery. It’s exciting to see such forward-thinking institutions embrace technologies that make a real difference in patient care. Read more about how Houston Methodist is redesigning healthcare and reimagining the patient experience: https://lnkd.in/gSE6Ejt7 #HealthcareInnovation #PatientCare #DigitalHealth